Elevance Health Inc., a leading health benefits company, is strategically positioning itself in the healthcare sector with a comprehensive portfolio of solutions. With robust operations catering to millions, its recent rebranding reflects an evolving identity. This analysis delves into its fundamental and historical performance metrics.
Elevance Health Inc. boasts a stable performance with some areas of improvement, as reflected in the fundamental scores.
Category | Score (1-5) | Visualization |
---|---|---|
Discounted Cash Flow | 5 | |
Return On Equity | 4 | |
Return On Assets | 4 | |
Debt To Equity | 1 | |
Price To Earnings | 2 | |
Price To Book | 3 |
Analysis of historical scores provides insights into the trend and stability of the company’s performance.
Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-09-26 | 3 | 5 | 4 | 4 | 1 | 2 | 3 |
N/A | 0 | 5 | 4 | 4 | 1 | 2 | 3 |
Analysts have set price targets highlighting potential growth, with a consensus leaning towards a "Buy" recommendation.
High | Low | Median | Consensus |
---|---|---|---|
$500 | $465 | $482.5 | $482.5 |
The analyst sentiment gauge suggests a favorable outlook, reinforced by a notable count of "Buy" recommendations.
Recommendation | Count | Distribution |
---|---|---|
Strong Buy | 0 | |
Buy | 28 | |
Hold | 9 | |
Sell | 0 | |
Strong Sell | 0 |
Elevance Health Inc. presents an overall stable performance with opportunities for improvement, particularly in reducing debt. The company's strong cash flow and equity returns are promising, and analysts maintain a positive outlook with a "Buy" consensus. Despite some volatility in debt ratios, its strategic initiatives underpin a robust growth narrative. Investors should weigh these dynamics against sector competitiveness.